Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma (SMM), and Multiple Myeloma Patient Experience With COVID-19 Survey
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- Quality of Life (QOL) Distress Screening tool
研究概览
简要总结
The purpose of this study is to examine how patients with multiple myeloma (MM) have been impacted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
The study will use a questionnaire to further understand how patients are being affected and gather information in order to track the long-term effects of the coronavirus.
The scope of the questionnaire will include, COVID-19 diagnosis and treatment, changes in myeloma treatment and care, clinical trial familiarity, health and fitness, and quality of life.
This questionnaire is a follow-on to the "MM and COVID-19" questionnaire.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients (greater than 18 years) diagnosed with MGUS, smoldering myeloma, and multiple myeloma.
- •Access to a computer or electronic device with internet access, or phone
- •Willing to create a patient profile on the HealthTree Cure Hub For Multiple Myeloma
- •Willing to give electronically-signed consent
- •Ability to read questions in English
排除标准
- 未提供
结局指标
主要结局
Quality of Life (QOL) Distress Screening tool
时间窗: Up to one year
Describe how patients rate their level of concern on psychosocial, practical, and physical needs during the COVID-19 pandemic using the Cancer Support Community's CancerSupportSource distress screening tool.
COVID-19 Diagnosis and Treatment
时间窗: Up to one year
Describe how patients diagnosed with COVID-19 were treated for the virus.
Changes to Myeloma Treatment and Care
时间窗: Up to one year
Describe which treatments were changed and how care was affected as a result of COVID-19
Health and Fitness
时间窗: Up to one year
Describe how COVID-19 impacted patient's health and fitness
次要结局
- Clinical Trial Familiarity(Upon enrollment)